FROM THE NEWS FEED
The Drug Enforcement Administration published Irvine Labs, Inc.'s application on 14 September 2026. The notice opens a comment period ending on 14 October 2026 and refers to supplementary information for details of the substances involved.
Continue to the original publication for the complete article.
KEEP EXPLORING
The study linked LSDβs slow dissociation from 5-HT2A receptors to prolonged Ξ²-arrestin signalling and antidepressant-...
Helus Pharma reported continued development of HLP003 for adjunctive treatment of major depressive disorder and HLP00...
The in vitro studies indicated favourable intestinal absorption, systemic exposure, metabolic stability across specie...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...